The modification structure of 1,4-benzoquinone is fascinating in the frame of drug design. The solubility properties of a new drug are important, especially for oral drug administration. The 2-isopropyl-5-methyl-1,4-benzoquinone (known as thymoquinone) which is the major constituent in Nigella sativa seed extract is known as an active compound with poor lipophilicity. Here, we reported the synthesis of 5-(4-bromobutyl)-2,3-dimethyl-1,4-benzoquinone which analog with thymoquinone having higher lipophilicity. The synthesis proposed by oxidation reaction of 2,3-dimethyl-1,4-hydroquinone (1) with H2SO4 followed by bromoalkylation reaction using bromopentanoic acid in the presence of AgNO3 and (NH4)2S2O8. The oxidation product 2,3-dimethyl-1,4-benzoquinone (2) and alkylated-quinone 5-(4-bromobutyl)-2,3-dimethyl-1,4-benzoquinone (3) were obtained in 52.64% and 5.85%, respectively. The FTIR analysis of 3 showed the additional C-Br stretching at 562 cm−1. The solubility test in n-octanol/water system using HPLC gave the log P value of 5-(4-bromobutyl)-2,3-dimethyl-1,4-benzoquinone (3) is 2.99, higher than thymoquinone. By this result, it is suggested that the modification of 1,4-benzoquinone by bromo alkylating agent increased the solubility of the compound.
Read full abstract